Physician profile
Joseph Gregory Lugo
NPI 1770582223
$4,030.32
in general payments reported to CMS, 2019-2025
20 companies · $241 in 2025
The $241 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $81.70 · 2021: $318 · 2022: $304 · 2023: $83.79 · 2024: $2,788 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $2,653 · Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $2,653.20 |
| Food and Beverage | $459.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $2,653.20 | 2024 | _level One Thoracic, Sterile, Plate, Rib, Locking, X Shp, 2.3 Mm Screw, 32 Hole, T=1.5 Mm, Cp Titanium, Qty: 001 Ea |
| Edwards Lifesciences Corporation | $323.35 | 2019-2024 | |
| Medtronic, INC. | $190.56 | 2021-2023 | Cardioblate |
| Endologix LLC | $179.37 | 2025 | Torus Stent Graft System, Endocross Device |
| Novartis Pharmaceuticals Corporation | $114.58 | 2019-2021 | |
| Ethicon US, LLC | $95.69 | 2022-2024 | Echelon Endopath, Surgicel Nu-Knit, Echelon Flex |
| Alnylam Pharmaceuticals INC. | $71.72 | 2022 | |
| Abiomed | $66.79 | 2021-2024 | Impella |
| Medtronic Vascular, INC. | $63.83 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.60 | 2021-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $41.47 | 2021-2024 | Eliquis |
| Getinge USA Sales, LLC | $38.03 | 2025 | Vasoview Hemopro 2 |
| Janssen Pharmaceuticals, INC | $31.92 | 2022 | |
| Davol INC. | $28.07 | 2021 | |
| Cvrx, INC. | $21.74 | 2023 | Barostim Neo System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16.68 | 2020 | |
| Silk Road Medical, INC. | $15.04 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Amarin Pharma, INC. | $13.23 | 2022 | |
| Amgen INC. | $12.85 | 2022 | |
| Kerecis Limited | $9.60 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lugo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.